Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Lymphoma; Neoplasms | Phase 1 | ClinicalTrials |
| Amyloidosis; Hodgkin Disease; Multiple Myeloma; Neoplasms, Plasma Cell; Paraproteinemias | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 3 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Lymphoid; Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 2 | ClinicalTrials |
| HIV Infections | Phase 2 | ClinicalTrials |
| Leukemia, Lymphocytic, Chronic, B-Cell | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 1/Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Breast Neoplasms; Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms | Phase 2 | ClinicalTrials |
| Graft vs Host Disease | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Depression | Phase 4 | ClinicalTrials |
| HIV Infections; Tetanus | Phase 2 | ClinicalTrials |
| Carcinoma; Ovarian Neoplasms | Phase 1 | ClinicalTrials |
| Urinary Bladder Neoplasms | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 3 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Leukemia; Myelodysplastic Syndromes; Preleukemia; Syndrome | Phase 1 | ClinicalTrials |
| Graft vs Host Disease | Phase 2 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial; Ovarian Neoplasms | Phase 1 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 2 | ClinicalTrials |
| Melanoma; Skin Neoplasms | Early Phase 1 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Carcinoma, Renal Cell; Kidney Neoplasms | Phase 3 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis; Motor Neuron Disease; Sclerosis | Phase 1 | ClinicalTrials |
| Melanoma; Neoplasm Metastasis | Phase 2 | ClinicalTrials |
| Carcinoma, Renal Cell; Kidney Neoplasms; Melanoma | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Carcinoma, Renal Cell | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell; Squamous Cell Carcinoma of Head and Neck | Phase 1/Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Disease Progression; Mesothelioma | Phase 1 | ClinicalTrials |
| Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid | Phase 2 | ClinicalTrials |
| Carcinoma, Renal Cell; Kidney Neoplasms | Phase 2 | ClinicalTrials |
| Melanoma | Phase 2/Phase 3 | ClinicalTrials |
| Neoplasm Metastasis | Phase 1 | ClinicalTrials |
| HIV Infections | Phase 2 | ClinicalTrials |
| HIV Seropositivity | Phase 2 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial; Fallopian Tube Neoplasms | Phase 1 | ClinicalTrials |
| Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Juvenile; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma, Myeloid | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 2 | ClinicalTrials |
| Neoplasm Metastasis | Phase 1 | ClinicalTrials |
| Neuroblastoma | Phase 2 | ClinicalTrials |
| Breast Neoplasms; Neoplasm Metastasis; Neoplasms | Phase 1 | ClinicalTrials |
| Melanoma; Neoplasm Metastasis | Phase 2 | ClinicalTrials |
| Alopecia; Alopecia Areata | Phase 1/Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 2 | ClinicalTrials |
| Adenocarcinoma; Carcinoma; Carcinoma, Ovarian Epithelial; Carcinosarcoma; Cystadenocarcinoma, Serous; Osteosarcoma; Ovarian Neoplasms | Phase 2 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome; HIV Infections; Immunologic Deficiency Syndromes; Infection | Phase 2 | ClinicalTrials |
| Carcinoma, Renal Cell; Kidney Neoplasms | Phase 2 | ClinicalTrials |
| Bone Neoplasms; Breast Neoplasms; Colonic Neoplasms; Colorectal Neoplasms; Eye Neoplasms; Lung Neoplasms; Melanoma; Osteosarcoma; Rectal Neoplasms; Sarcoma | Phase 1 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 2 | ClinicalTrials |
| Breast Neoplasms | Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 1/Phase 2 | ClinicalTrials |
| Myelodysplastic Syndromes; Preleukemia; Syndrome | Phase 2 | ClinicalTrials |
| Neuroblastoma | Phase 1 | ClinicalTrials |
| Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasms | Phase 2 | ClinicalTrials |
| Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Myeloproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Preleukemia | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Colorectal Neoplasms | Phase 2 | ClinicalTrials |
| Amputation, Traumatic | Early Phase 1 | ClinicalTrials |
| Graft vs Host Disease | Phase 1 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome; HIV Infections; Immunologic Deficiency Syndromes | Phase 1 | ClinicalTrials |
| Infection | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| HIV Infections | Phase 2 | ClinicalTrials |
| Melanoma | Phase 3 | ClinicalTrials |
| Graft vs Host Disease | Phase 2 | ClinicalTrials |
| Hodgkin Disease; Lymphoma | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, B-Cell | Phase 1 | ClinicalTrials |
| Communicable Diseases; HIV Infections; Infection | Phase 2 | ClinicalTrials |
| Muscular Diseases; Myositis | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Lymphoma; Neuroblastoma | Phase 1 | ClinicalTrials |
| Giant Cell Arteritis; Polymyalgia Rheumatica | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Sarcoma | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Hepatocellular | Phase 1 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 2 | ClinicalTrials |
| Kidney Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 2 | ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 1 | Phase 1 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute | Phase 1/Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Mantle-Cell | Phase 2 | ClinicalTrials |
| Macrophage Activation Syndrome; Syndrome | Phase 1/Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1 | ClinicalTrials |
| Graft vs Host Disease | Phase 2 | ClinicalTrials |
| Mesothelioma | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 1 | ClinicalTrials |
| Peritoneal Neoplasms | Phase 1 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Infection | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell | Phase 1 | ClinicalTrials |
| Syndrome; Thrombocytopenia; Wiskott-Aldrich Syndrome | Phase 1 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Acquired Immunodeficiency Syndrome; Hepatitis; Hepatitis A; Hepatitis B; HIV Infections; Infection | Phase 3 | ClinicalTrials |
| Melanoma | Phase 3 | ClinicalTrials |
| Leukemia, B-Cell; Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1/Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Carcinoma; Hodgkin Disease; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Neoplasms; Stomach Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Lymphoma; Lymphoma, Non-Hodgkin | Phase 2 | ClinicalTrials |
| Graft vs Host Disease | Phase 1 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis; Motor Neuron Disease; Sclerosis | Phase 2 | ClinicalTrials |
| Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma, Ovarian Epithelial; Ovarian Neoplasms | Phase 1/Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell; Neoplasm Metastasis | Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Melanoma | Phase 1 | ClinicalTrials |
| Carcinoma; Carcinoma, Renal Cell; Melanoma | Phase 1/Phase 2 | ClinicalTrials |
| Myelodysplastic Syndromes | Phase 2 | ClinicalTrials |
| Melanoma | Phase 2 | ClinicalTrials |
| Leukemia | Phase 1 | ClinicalTrials |
CONTENTS